DalsnaFinance › IPOs › Contineum Therapeutics › IPO
Contineum Therapeutics, Inc. completed its initial public offering on NASDAQ on April 5, 2024, pricing at $16.00 a share.
| Ticker | CTNM |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | April 5, 2024 |
| Offering price | $16.00 |
| Shares offered | 6,875,000 |
| Total raised | $110M |
Contineum Therapeutics, Inc. sold 6,875,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $110 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $110 million total recorded for the deal.
Contineum Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Contineum Therapeutics, Inc.. This page is general information, not investment advice.